First defined in the mid-1990s, prebiotics, which alter the composition and activity of gastrointestinal (GI) microbiota to improve health and well-being, have generated scientific and consumer interest and regulatory debate. The Life Sciences Research Organization, Inc. (LSRO) held a workshop, Prebiotics and the Health Benefits of Fiber: Future Research and Goals, in February 2011 to assess the current state of the science and the international regulatory environment for prebiotics, identify research gaps, and create a strategy for future research. A developing body of evidence supports a role for prebiotics in reducing the risk and severity of GI infection and inflammation, including diarrhea, inflammatory bowel disease, and ulcerative colitis as well as bowel function disorders, including irritable bowel syndrome. Prebiotics also increase the bioavailability and uptake of minerals and data suggest that they reduce the risk of obesity by promoting satiety and weight loss. Additional research is needed to define the relationship between the consumption of different prebiotics and improvement of human health. New information derived from the characterization of the composition and function of different prebiotics as well as the interactions among and between gut microbiota and the human host would improve our understanding of the effects of prebiotics on health and disease and could assist in surmounting regulatory issues related to prebiotic use.
Lot of the scientific interest on functional foods is directed towards the use of inulin and oligofructose as ingredients to enhance calcium absorption. Over the past 10 years, experiments in animal models have repeatedly shown that inulin and oligofructose increase calcium availability. Long term beneficial effects of inulin and oligofructose in growing rats were demonstrated by accumulation of bone mineral and improved structure of the trabecular network.. These experimental data about the effects of inulin and oligofructose for improving bone health in animal models support the hypothesis that increased calcium absorption might also positively influence peak bone mass in humans, especially during adolescence. Studies in adolescent boys confirmed this hypothesis by demonstrating an increase (> 25 %, p < 0.05) in their true fractional calcium absorption after ingestion of 15 g OF per day (1). Subsequent studies on calcium availability using similar methodologies e.g. stable isotopes showed corresponding effects. In girls with adequate calcium intakes, 8 g daily of a oligofructose-enriched inulin, increased their true absolute calcium absorption by almost 20 % (2). More detailed study on the subject characteristics revealed that those girls with lower calcium absorption at baseline showed the greatest benefit by Oligofructose-enriched inulin -supplementation (3). Recently, data from a long term prospective study focused on the changes in mineral accretion in 100 pre-pubertal girls and boys after 1 y again showed a significant increase in the calcium absorption after 2 months and this effect lasted during the whole year of the intervention (4). This resulted in a significant increase in the bone mineral density and the bone mineral content of the active group vs. the placebo (P<0.05). Data from this long term prospective study will be presented and the implications for relating health claims discussed. The benefits of this improved calcium absorption for postponing osteoporosis were further demonstrated in postmenopausal women. The absorption of Ca, Mg and biomarkers related to Ca absorption and bone formation were monitored. Emerging data on other health aspects include biomarkers related to immune modulation and appetite/satiety control. (1) Van den Heuvel et al. (1999) Am.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.